Zurcher Kantonalbank Zurich Cantonalbank Has $299,000 Holdings in Stevanato Group S.p.A. (NYSE:STVN)

Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Stevanato Group S.p.A. (NYSE:STVN) by 25.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,814 shares of the company’s stock after purchasing an additional 2,214 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Stevanato Group were worth $299,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Raymond James & Associates increased its holdings in Stevanato Group by 0.9% in the 3rd quarter. Raymond James & Associates now owns 197,316 shares of the company’s stock valued at $5,864,000 after buying an additional 1,806 shares during the period. Calamos Wealth Management LLC acquired a new stake in shares of Stevanato Group during the 3rd quarter valued at about $1,456,000. Conestoga Capital Advisors LLC increased its stake in Stevanato Group by 19.7% in the third quarter. Conestoga Capital Advisors LLC now owns 4,534,088 shares of the company’s stock valued at $134,753,000 after acquiring an additional 746,136 shares during the period. Fifth Third Bancorp raised its position in Stevanato Group by 70.1% in the third quarter. Fifth Third Bancorp now owns 2,473 shares of the company’s stock worth $73,000 after purchasing an additional 1,019 shares in the last quarter. Finally, Sivik Global Healthcare LLC lifted its stake in Stevanato Group by 8.7% during the third quarter. Sivik Global Healthcare LLC now owns 76,072 shares of the company’s stock worth $2,261,000 after purchasing an additional 6,072 shares during the period.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on STVN shares. Stephens reiterated an “overweight” rating and issued a $38.00 price objective on shares of Stevanato Group in a research note on Monday, March 25th. BNP Paribas assumed coverage on Stevanato Group in a research report on Monday, April 22nd. They issued an “outperform” rating on the stock. Finally, Morgan Stanley reiterated an “equal weight” rating and set a $30.00 price objective on shares of Stevanato Group in a research note on Monday, April 22nd. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of €34.29 ($36.87).

Stevanato Group Price Performance

NYSE STVN opened at €26.45 ($28.44) on Monday. The stock’s 50 day simple moving average is €29.63 and its 200 day simple moving average is €29.13. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.50. Stevanato Group S.p.A. has a one year low of €23.00 ($24.73) and a one year high of €36.30 ($39.03).

Stevanato Group (NYSE:STVN) last announced its earnings results on Thursday, March 7th. The company reported €0.18 ($0.19) EPS for the quarter, missing the consensus estimate of €0.19 ($0.20) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 14.31% and a net margin of 13.43%. The business had revenue of €320.60 million for the quarter, compared to the consensus estimate of €326.85 million. During the same quarter in the previous year, the company posted $0.19 EPS. Stevanato Group’s revenue for the quarter was up 9.8% on a year-over-year basis. Sell-side analysts anticipate that Stevanato Group S.p.A. will post 0.67 EPS for the current fiscal year.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.